Skip to main content
Clinical Trials/ACTRN12605000406606
ACTRN12605000406606
Completed
Phase 3

The effects of a nutritional supplementation on premenstrual syndrome

Swisse Bio Juven0 sites60 target enrollmentSeptember 14, 2005

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Premenstrual syndrome
Sponsor
Swisse Bio Juven
Enrollment
60
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 14, 2005
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Swisse Bio Juven

Eligibility Criteria

Inclusion Criteria

  • Healthy women with regular menstrual cycles of 25 \- 35 days. Women who defined themselves as experiencing premenstrual syndrome regularly during the previous 12 months. Individuals who agreed to avoid all nutritional supplements during their involvement in the trial. Individuals who agreed to record all medications used throughout the study.

Exclusion Criteria

  • Subjects who were lactating or had stopped lactating within 3 months of commencement of the study. Subjects who had changed their use of oral contraceptives within 3 months of commencement of the study. Subjects who were undergoing treatment for PMS. Subjects who were taking regular medication. Subjects who were experiencing any undue stress or relationship problem. Subjects who experience photosensitive skin reactions or hypersensitivity to ginger. Any disease particularly conditions that interact with gonadotrophins or their releasing factors and those that compromise digestion or absorption of micronutrients. Any significant health complaint, problem or disease that in the opinion of the researcher would compromise the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials